ON DEMAND
Built to Scale: Smart Comprehensive Genomic Profiling with a Decentralized Solution
Comprehensive genomic profiling (CGP) is transforming precision oncology by enabling more precise and personalized cancer care. However, as demand for testing grows, many clinical laboratories face significant operational hurdles—from fragmented and rigid analysis workflows to long turnaround times. Decentralized testing enables laboratories to perform large-scale molecular analysis in-house, retain full control of their data, and streamline workflows to accelerate time to results.
In this Inside Precision Medicine webinar, Cristovam Scapulatempo Neto, MD, PhD, will explore how a decentralized, tech-agnostic approach can help laboratories expand their CGP capabilities. Using SOPHiA DDM™ for CGP by SOPHiA GENETICS as an example, he will discuss how this advanced analytical solution, which is designed to be compatible with a wide range of sequencing platforms, helps laboratories streamline processes and scale testing without compromising accuracy.
The webinar will provide insights into what the solution offers, including:
- A sample-to-report workflow with fully integrated analysis, interpretation and reporting features.
- Robust analytical performance for complex biomarker detection from both DNA and RNA, powered by proprietary noise-reduction technology and artificial intelligence algorithms.
- Improved operational efficiency and turnaround times enabled by a streamlined workflow.
- Flexible approach to address your specific research needs, made possible by the sequencer-agnostic design and modular architecture of the SOPHiA DDM™ Platform.